Diabetic ketoacidosis during treatment with sodium-glucose cotransporter 2 inhibitors reveals a latent autoimmune diabetes in adult

Minerva Endocrinol (Torino). 2022 Dec;47(4):475-476. doi: 10.23736/S2724-6507.21.03432-5. Epub 2021 Apr 15.

Authors

Elisabetta Nardella¹, Stefano D'Addio¹, Clelia Cipolla², Raffaele Manna^{1

3}

Affiliations

¹ Department of Internal Medicine, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
² Department of Life Sciences and Global Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy - clelia.cipolla@policlinicogemelli.it.
³ Rare Diseases and Periodic Fevers Research Center, Sacred Heart Catholic University, Rome, Italy.

PMID: 33855387
DOI: 10.23736/S2724-6507.21.03432-5

No abstract available

MeSH terms

Adult
Diabetes Mellitus, Type 1* / drug therapy
Diabetic Ketoacidosis* / chemically induced
Glucose
Humans
Latent Autoimmune Diabetes in Adults*
Sodium

Substances

Glucose
Sodium